Patterns, Risk Factors, and Outcomes of Recurrence After Hepatectomy for Hepatocellular Carcinoma with and without Microvascular Invasion
DOI: https://doi.org/10.2147/jhc.s438850
2024-05-08
Journal of Hepatocellular Carcinoma
Abstract:Yang Yu, 1, &ast Xiao-Hui Wang, 2, &ast Wen-Jie Hu, 1 De-Hua Chen, 1 Zi-Li Hu, 3 Shao-Qiang Li 1 1 Hepatic Pancreatobiliary Surgery Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, People's Republic of China; 2 Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University) Changsha, Hunan Province, 410005, People's Republic of China; 3 Department of Liver Surgery, Sun Yat-Sen University Cancer Center, Guangdong, 510060, Guangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shao-Qiang Li, Hepatic Pancreatobiliary Surgery Center, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, People's Republic of China, Tel +86-020-87755766-8214, Fax +86-020-87755766-8661, Email Purpose: The patterns and risk factors of postsurgical recurrence of patient with hepatocellular carcinoma (HCC) with microvascular invasion (MVI) are not clarified. This study aimed to decipher and compare the postoperative recurrent patterns and the risk factors contributing to recurrence between MVI positive (MVI (+) ) and MVI negative (MVI (-) ) HCC after hepatectomy. Patients and methods: Patients with HCC who underwent hepatectomy in three Chinese academic hospitals between January 1, 2009, and December 31, 2018, were enrolled. Recurrent patterns included early (≤ 2 years) or late (> 2 years) recurrence, recurrent sites and number, and risk factors of recurrence were compared between the MVI (+) and MVI (-) groups by propensity score–matching (PSM). Results: Of 1756 patients included, 581 (33.1%) were MVI (+) , and 875 (49.8%) patients developed early recurrence. Compared with the MVI (-) group, the MVI (+) group had a higher 2-year recurrence rate in the PSM cohort (hazard ratio [HR], 1.82; 95% confidence interval [CI], 1.59– 2.10; P < 0.001), and more patients with multiple tumor recurrence. Patients with early recurrence in the MVI (+) group had a worse overall survival (OS) than those in the MVI (-) group (HR, 1.24; 95% CI, 1.02– 1.50; P = 0.034). Resection margin (RM) ≤ 1.0 cm is a surgical predictor of early recurrence for the MVI (+) group (HR, 0.68; 95% CI, 0.54– 0.87; P = 0.002), but not for the MVI (-) group. Conclusion: Compared to MVI (-) HCC, MVI (+) HCC tends to be early, multiple recurrence and lung and lymph node metastasis after resection. RM ≤ 1.0 cm is a surgical risk factor of early recurrence for patient with MVI. Keywords: hepatocellular carcinoma, microvascular invasion, recurrence patterns, risk factors, outcomes Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. It is the second leading cancer-related death in China. 1 Liver resection is the potential curative treatment for HCC with good liver function reserve. As the refinement of surgical technique and improvement of pre-operative evaluation, the postsurgical morbidity and mortality of HCC have been substantially improved. 2,3 However, the recurrent rate remains high after resection. The 5-year recurrent rate ranged from 57.7 to 70% even for patients with early HCC. 4–6 Microvascular invasion (MVI), defined as tumor cells in the lumen covered by epithelial cells, is a malignant feature of HCC. 7 The incidence of MVI in resected HCC specimens ranged from 15 to 57.1%. 8 In the past 10 years, increasing evidence showed that MVI is a pivotal risk pathologic trait contributing to tumor recurrence after resection of HCC. 9–13 However, these previous reports mainly focused on the risk of recurrence of MVI, the patterns and risk factors of recurrence after liver resection for HCC with MVI (MVI (+) HCC), and whether they are different from MVI (-) HCC are not clarified. In the present study, we aimed to decipher and compare the postoperative recurrent patterns and the risk factors contributing to recurrence between MVI (+) HCC and MVI (-) HCC after liver resection based on a multicenter HCC database. Consecutive patients with HCC who underwent initially liver resection with curative intent at three Chinese academic hospitals: the First Affiliated Hospital of Sun Yat-sen University (January 1, 2009 –December 31, 2018), the Cancer Center of Sun Yat-sen University (January 1, 2010-December, 2014) and the Hunan Provincial People's Hospital (January 1, 2010-December 31, 2016) were collected retrospectively. Only patients with Barcelona Clin -Abstract Truncated-
oncology